A recent analysis from the Peterson Center on Healthcare and the Kaiser Family Foundation provides an incomplete picture of U.S. spending on health care while downplaying the “immense role” that drug costs play, writes Aaron Wesolowski, AHA’s vice president of policy research, analytics and strategy, for the AHA Stat Blog. Read more.

Related News Articles

Blog
The availability of swift, accurate and reliable diagnostic testing during the public health emergency has been extremely important. Lab testing is essential…
Headline
The AHA and American Society of Health-System Pharmacists today urged the Food and Drug Administration to take appropriate enforcement action to protect…
Headline
Instead of attacking hospitals and health systems caring for patients during the COVID-19 pandemic, PhRMA should instead focus on lowering the costs of drugs…
Blog
America’s hospitals and health systems, and our heroic caregivers, have been on the front lines of the battle against COVID-19 for the past year, working…
Headline
AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with…
Headline
U.S. spending on health care grew 4.6% in 2019, similar to 2018 but slightly more than overall growth in the economy, the Centers for Medicare & Medicaid…